Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-19-028991
Filing Date
2019-05-13
Accepted
2019-05-13 17:13:38
Documents
4
Effectiveness Date
2019-05-13

Document Format Files

Seq Description Document Type Size
1 DEFA14A a19-9748_2defa14a.htm DEFA14A 51292
2 EX-99.1 a19-9748_2ex99d1.htm EX-99.1 10085
3 GRAPHIC g97481mmi001.jpg GRAPHIC 2842
4 GRAPHIC g97481bai001.jpg GRAPHIC 3084
  Complete submission text file 0001104659-19-028991.txt   70904
Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33497 | Film No.: 19819348
SIC: 2834 Pharmaceutical Preparations